688329.SH
艾隆科技
SSE · Healthcare · Medical - Equipment & Services · CN
CNY 20.21
−3.53%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 427.2M | 441.8M | 325.3M | 363.6M | 477.4M |
| Cost of Revenue | 217.8M | 224.3M | 178.7M | 177.7M | 225.4M |
| Gross Profit | 209.5M | 217.5M | 146.6M | 185.9M | 251.9M |
| Operating Expenses | |||||
| R&D Expense | 61.8M | 60.1M | 57.9M | 55.2M | 45.1M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 74.3M | 68.6M | 44.5M | 44.2M | 38.0M |
| Selling & Marketing Expense | 58.1M | 59.8M | 63.4M | 58.1M | 52.8M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 207.0M | 201.7M | 177.1M | 167.6M | 144.9M |
| Cost and Expenses | 424.8M | 426.0M | 355.8M | 345.3M | 370.4M |
| Operating Income (EBIT) | 5.6M | 16.7M | (24.4M) | 34.7M | 116.3M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 6.1M | 17.2M | (24.4M) | 34.6M | 115.7M |
| Income Tax Expense | (3.6M) | (2.6M) | (2.1M) | 6.1M | 14.2M |
| Bottom Line | |||||
| Net Income | 9.6M | 18.6M | (21.7M) | 29.5M | 102.0M |
| Earnings from Cont. Ops | 9.7M | 19.8M | (22.3M) | 28.4M | 101.5M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 9.6M | 18.6M | (21.7M) | 29.5M | 102.0M |
| Per Share | |||||
| Basic EPS | CN¥0.08 | CN¥0.25 | (CN¥0.29) | CN¥0.39 | CN¥1.33 |
| Diluted EPS | CN¥0.08 | CN¥0.25 | (CN¥0.29) | CN¥0.39 | CN¥1.33 |
| Revenue Per Share | CN¥6.28 | CN¥5.95 | CN¥4.35 | CN¥4.80 | CN¥6.22 |
| Shares | |||||
| Basic Shares Outstanding | 68.0M | 74.2M | 74.8M | 75.7M | 76.7M |
| Diluted Shares Outstanding | 68.0M | 74.2M | 74.8M | 75.7M | 76.7M |
| Profitability Metrics | |||||
| EBITDA | — | 50.4M | 2.7M | 51.2M | 134.6M |
| D&A | — | 33.7M | 27.2M | 16.5M | 18.3M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026